{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:13:48Z","timestamp":1771010028658,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s12022-008-9052-0","type":"journal-article","created":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T09:17:36Z","timestamp":1228123056000},"page":"252-260","source":"Crossref","is-referenced-by-count":13,"title":["Immunohistochemical Analysis of 11-\u03b2-Hydroxysteroid Dehydrogenase Type 2 and Glucocorticoid Receptor in Subclinical Cushing\u2019s Disease due to Pituitary Macroadenoma"],"prefix":"10.1007","volume":"19","author":[{"given":"Takanori","family":"Ebisawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyoshi","family":"Tojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Kamio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Oki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,2]]},"reference":[{"key":"9052_CR1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1210\/edrv.20.2.0358","volume":"20","author":"PL Dahia","year":"1999","unstructured":"Dahia PL, Grossman AB. The molecular pathogenesis of corticotroph tumors. Endocr Rev. 20:136\u201355, 1999. doi: 10.1210\/er.20.2.136 .","journal-title":"Endocr Rev."},{"key":"9052_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0303-7207(02)00280-0","volume":"197","author":"SWJ Lamberts","year":"2002","unstructured":"Lamberts SWJ. Glucocrticoid receptors and Cushing\u2019s disease. Mol Cell Endocrinol. 197:69\u201372, 2002. doi: 10.1016\/S0303-7207(02)00280-0 .","journal-title":"Mol Cell Endocrinol."},{"key":"9052_CR3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jcb.240350404","volume":"35","author":"J Drouin","year":"1987","unstructured":"Drouin J, Charron J, Gagner JP, Jeannotte L, Nemer M, Plante RK, Wrange O. Pro-opiomelanocortin gene: a model for negative regulation of transcription by glucocorticoids. J Cell Biochem. 35:293\u2013304, 1987. doi: 10.1002\/jcb.240350404 .","journal-title":"J Cell Biochem."},{"key":"9052_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-0004.2007.00877.x","volume":"72","author":"J Drouin","year":"2007","unstructured":"Drouin J, Bilodeau S, Vallette S. Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency. Clin Genet. 72:175\u201382, 2007. doi: 10.1111\/j.1399-0004.2007.00877.x .","journal-title":"Clin Genet."},{"key":"9052_CR5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2265.2001.01323.x","volume":"55","author":"M Ruiz","year":"2001","unstructured":"Ruiz M, Lind U, Gafvels M, Eggertsen G, Carlstedt-Duke J, Nilsson L, Holtmann M, Stierna P, Wilkstrom A, Werner S. Characterization of two novel mutations in the glucocrticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol. 55:363\u201371, 2001. doi: 10.1046\/j.1365-2265.2001.01323.x .","journal-title":"Clin Endocrinol."},{"key":"9052_CR6","first-page":"296","volume":"108","author":"M Karl","year":"1996","unstructured":"Karl M, Lamberts SW, Koper JW, Katz DA, Huizenga NE, Kino T, Haddad BR, Hudhes MR, Chrousos GP. Cushing\u2019s disease preceded by generalized glucocorticoid resistance: clinical consequence of a novel, dominant-negative glucocorticoid receptor mutation. Proc Assoc Am Physicians 108:296\u2013307, 1996.","journal-title":"Proc Assoc Am Physicians"},{"key":"9052_CR7","first-page":"124","volume":"81","author":"M Karl","year":"1996","unstructured":"Karl M, Wichert GV, Kempter E, Katz DA, Reincke M, Monig H, Ali IU, Stratakis CA, Oldfield EH, Chrousos GP, Schulte HM. Nelson\u2019s syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene. J Clin Endocrinol Metab. 81:124\u20139, 1996. doi: 10.1210\/jc.81.1.124 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9052_CR8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jc.2006-1328","volume":"92","author":"G Assie","year":"2007","unstructured":"Assie G, Bahurel H, Coste J, Silvera S, Kujas M, Dugue MA, Karray F, Dousset B, Bertherat J, Legmann P, Bertagna X. Corticotroph tumor progression after adrenalectomy in Cushing\u2019s disease: a reappraisal of Nelson\u2019s syndrome. J Clin Endocrinol Metab. 92:172\u20139, 2007. doi: 10.1210\/jc.2006-1328 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9052_CR9","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1210\/endo.131.6.1332850","volume":"131","author":"MD Woods","year":"1992","unstructured":"Woods MD, Shipston MJ, Mullens EL, Antoni FA. Pituitary corticotrope tumor (AtT20) cells as a model system for the study of early inhibition by glucocorticoids. Endocrinology. 131:2873\u201380, 1992. doi: 10.1210\/en.131.6.2873 .","journal-title":"Endocrinology."},{"key":"9052_CR10","first-page":"1619","volume":"83","author":"L Katznelson","year":"1998","unstructured":"Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A. Biochemical assessment of Cushing\u2019s disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metab. 83:1619\u201323, 1998. doi: 10.1210\/jc.83.5.1619 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9052_CR11","first-page":"2728","volume":"86","author":"M Korbonits","year":"2001","unstructured":"Korbonits M, Bujalska I, Shimojo M, Nobes J, Jordan S, Grossman AB, Stewart PM. Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors. J Clin Endocrinol Metab. 86:2728\u201333, 2001. doi: 10.1210\/jc.86.6.2728 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9052_CR12","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.onc.1206293","volume":"22","author":"EH Rabbitt","year":"2003","unstructured":"Rabbitt EH, Ayuk J, Boelaert K, Sheppard MC, Hewison M, Stewart PM, Gittoes NJ. Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation. Oncogene. 22:1663\u20137, 2003. doi: 10.1038\/sj.onc.1206293 .","journal-title":"Oncogene."},{"key":"9052_CR13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1677\/joe.1.06019","volume":"186","author":"N Draper","year":"2005","unstructured":"Draper N, Stewart PM. 11 \u03b2-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol. 186:251\u201371, 2005. doi: 10.1677\/joe.1.06019 .","journal-title":"J Endocrinol."},{"key":"9052_CR14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/en.2005-0544","volume":"147","author":"T Nigawara","year":"2006","unstructured":"Nigawara T, Iwasaki Y, Asai M, Yoshida M, Kambayashi M, Sashinami H, Hashimoto K, Suda T. Inhibition of 11beta-hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells. Endocrinology. 147:769\u201372, 2006. doi: 10.1210\/en.2005-0544 .","journal-title":"Endocrinology."},{"key":"9052_CR15","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/archinte.161.6.892","volume":"161","author":"T Takao","year":"2001","unstructured":"Takao T, Mimoto T, Yamamoto M, Hshimoto K. Preclinical Cushing\u2019s disease. Arch Intern Med. 161:892\u20133, 2001. doi: 10.1001\/archinte.161.6.892 .","journal-title":"Arch Intern Med."},{"key":"9052_CR16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2169\/internalmedicine.41.566","volume":"41","author":"T Nagai","year":"2002","unstructured":"Nagai T, Imamura M, Misumi S, Mori M. Subclinical Cushing\u2019s disease accompanied by malignant hypertension and diabetes mellitus. Intern Med. 41:566\u201370, 2002. doi: 10.2169\/internalmedicine.41.566 .","journal-title":"Intern Med."},{"key":"9052_CR17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1507\/endocrj.50.325","volume":"50","author":"K Kageyama","year":"2003","unstructured":"Kageyama K, Moriyama T, Sakihara S, Kawashima S, Suda T. A case of preclinical Cushing\u2019s disease, accompanied with thyroid papillary carcinoma and adrenal incidentaloma. Endocr J. 50:325\u201331, 2003. doi: 10.1507\/endocrj.50.325 .","journal-title":"Endocr J."},{"key":"9052_CR18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/eje.0.1490195","volume":"149","author":"S Cannavo","year":"2003","unstructured":"Cannavo S, Almoto B, Asta CD, Corsello S, Lovicu RM, Menis ED, Trimarchi F, Ambrosi B. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas. Eur J Endocrinol. 149:195\u2013200, 2003. doi: 10.1530\/eje.0.1490195 .","journal-title":"Eur J Endocrinol."},{"key":"9052_CR19","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2005-0070","volume":"90","author":"YS Woo","year":"2005","unstructured":"Woo YS, Ishidori AM, Wat WZ, Kaltsas GA, Afshar F, Sabin I, Jenkins PJ, Monson JP, Besser GM, Grossman AB. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas. J Clin Endocrinol Metab. 90:4963\u20139, 2005. doi: 10.1210\/jc.2005-0070 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9052_CR20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1677\/joe.0.1520387","volume":"152","author":"HS Kooistra","year":"1997","unstructured":"Kooistra HS, Voorhout G, Mol JA, Rijinberk A. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol. 152:387\u201394, 1997. doi: 10.1677\/joe.0.1520387 .","journal-title":"J Endocrinol."},{"key":"9052_CR21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0739-7240(02)00128-5","volume":"22","author":"JT Bosje","year":"2002","unstructured":"Bosje JT, Rijinberk A, Mol JA, Voorhout G, Kooistra HS. Plasma concentration of ACTH precursors correlate with pituitary size and resistance to dexamethasone in dogs with pituitary-dependent hyperadrenocorticism. Domest Anim Endocrinol. 22:201\u201310, 2002. doi: 10.1016\/S0739-7240(02)00128-5 .","journal-title":"Domest Anim Endocrinol."},{"key":"9052_CR22","first-page":"4022","volume":"83","author":"T Suzuki","year":"1998","unstructured":"Suzuki T, Sasano H, Suzuki S, Hirasawa G, Takeyama J, Muramatsu Y, Date F, Nagura H, Krozowski ZS. 11 \u03b2-Hydroxysteroid dehydrogenase type 2 in human lung: possible regulator of mineralocorticoid action. J Clin Endocrinol Metab. 83:4022\u20135, 1998. doi: 10.1210\/jc.83.11.4022 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9052_CR23","first-page":"2203","volume":"80","author":"ZS Krozowski","year":"1995","unstructured":"Krozowski ZS, Maguire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK. Immunohistochemical localization of the 11\u03b2-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab. 80:2203\u20139, 1995. doi: 10.1210\/jc.80.7.2203 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9052_CR24","first-page":"497","volume":"81","author":"S Gibson","year":"1996","unstructured":"Gibson S, Ray DW, Crosby SR, Dornan TL, Jennings AM, Bevan JS, Davis JRE, White A. Impaired processing of pro-opiomelanocortin in invasive corticotroph adenomas. J Clin Endocrinol Metab. 81:497\u2013502, 1996. doi: 10.1210\/jc.81.2.497 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9052_CR25","first-page":"835","volume":"78","author":"S Gibson","year":"1994","unstructured":"Gibson S, Crosby SR, Stewart MF, McCall E, White A. Differential release of pro-opiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays. J Clin Endocrinol Metab. 78:835\u201341, 1994. doi: 10.1210\/jc.78.4.835 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9052_CR26","first-page":"917","volume":"83","author":"NATM Huizenga","year":"1998","unstructured":"Huizenga NATM, Lange P, Koper JW, Clayton RN, Farreli WE, Lely AJ, Brinkmann AO, Jong FH, Lamberts SWJ. Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucoocrticoid receptor gene locus. J Clin Endocrinol Metab. 83:917\u201321, 1998. doi: 10.1210\/jc.83.3.917 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9052_CR27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2265.1998.00520.x","volume":"49","author":"YM Mu","year":"1998","unstructured":"Mu YM, Tkayanagi R, Imasaki K, Ohe K, Ikuyama S, Ynase T, Nawata H. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing\u2019s disease with resistance to a high dose-dexamethasone suppression test. Clin Endocrinol. 49:301\u20136, 1998. doi: 10.1046\/j.1365-2265.1998.00520.x .","journal-title":"Clin Endocrinol."},{"key":"9052_CR28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/joe.0.1560169","volume":"156","author":"T Okabe","year":"1998","unstructured":"Okabe T, Takayanagi R, Adachi M, Imasaki K, Nawata H. Nur77, a member of the steroid receptor superfamily, antagonizes negative feedback of ACTH synthesis and secretion by glucocorticoid in pituitary corticotrope cells. J Endocrinol. 156:169\u201375, 1998. doi: 10.1677\/joe.0.1560169 .","journal-title":"J Endocrinol."},{"key":"9052_CR29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1210\/me.2004-0333","volume":"19","author":"C Martens","year":"2005","unstructured":"Martens C, Bilodeau S, Maira M, Gauthier Y, Drouin J. Protein\u2013protein interactions and transcriptional antagonism between the subfamily of NGFI-B\/Nur77 orphan nuclear receptors and glucocorticoid receptor. Mol Endocrinol. 19:885\u201397, 2005. doi: 10.1210\/me.2004-0333 .","journal-title":"Mol Endocrinol."}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-008-9052-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-008-9052-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-008-9052-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:57:28Z","timestamp":1559440648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-008-9052-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["9052"],"URL":"https:\/\/doi.org\/10.1007\/s12022-008-9052-0","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}